MedTrace Logo

RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY

NCT05570487 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2022-10-25

No results posted yet for this study

Summary

To clarify the effect of the number of lymph node dissection and the number of stations on survival

Conditions

  • the Records of Esophageal Cancer

Interventions

DIAGNOSTIC_TEST

Since the data were collected retrospectively, there were no interventions

Since the data were collected retrospectively, there were no interventions

Sponsors & Collaborators

  • Yongtao Han

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2022-12-01
Completion
2023-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05570487 on ClinicalTrials.gov